Skip to main content
. Author manuscript; available in PMC: 2021 May 25.
Published in final edited form as: Leuk Res. 2019 Feb 28;79:38–44. doi: 10.1016/j.leukres.2019.02.012

Table 3.

Baseline MPN-SAD symptom scores*.

Leadin (N = 21)
Severe Subset (n = 14)
Mean Median Mean Median
Bone pain 1.87 1.00 2.71 2.36
Problems with concentration 2.52 1.86 3.36 3.29
Abdominal discomfort 3.65 2.86 4.73 5.00
Fatigue 4.34 4.86 5.84 5.64
Fever (> 37.8 °C) 0.37 0.00 0.56 0.00
Early satiety 3.69 3.86 4.74 4.93
Inactivity 3.45 3.29 4.76 5.07
Pruritus 1.51 0.86 1.83 1.14
Night sweats 1.95 1.14 2.79 3.36
Unintentional weight loss 0.66 0.14 0.83 0.36
Spleen-related symptom score 7.33 6.86 9.48 9.86
Constitutional symptom score§ 9.67 7.71 13.16 14.07
Total symptom score 24.00 24.86 32.14 30.36
nTssǁ 17.00 17.43 22.64 22.00

MPN-SAD = Myeloproliferative Neoplasm Symptom Assessment Diary; nTSS = new total symptom score.

*

Large values correspond to worse symptoms.

Severe Subset included patients with a baseline (7-day average) MPN-SAD severity score ≥ 5 (on 0–10 scale) on at least one, or a severity score ≥3 on at least two of the following items: fatigue, early satiety, abdominal discomfort, inactivity, night sweats, pruritus, and/or bone pain.

Spleen-related symptom score is the sum of early satiety and abdominal discomfort.

§

Constitutional symptom score is the sum of fatigue, night sweats, pruritus, and bone pain.

ǁ

nTSS is the sum of spleen-related symptoms and constitutional symptoms.